Goldman Sachs Group »

Cellectar Biosciences shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $88k 35k 2.50

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Cellectar Biosciences

Rosalind Advisors
AIGH Capital Management
Nantahala Capital Management
Vanguard Group
Geode Capital Management
BlackRock
BlackRock
Bank of America Corporation
Barclays
State Street Corporation
Morgan Stanley
Citadel Advisors
Northern Trust
Susquehanna International
Goldman Sachs Group

View all funds holding Cellectar Biosciences